Click and bioorthogonal chemistry: the future of active targeting of nanoparticles for nanomedicines?

L Taiariol, C Chaix, C Farre, E Moreau - Chemical Reviews, 2021 - ACS Publications
Over the years, click and bioorthogonal reactions have been the subject of considerable
research efforts. These high-performance chemical reactions have been developed to meet …

Ultrasmall superparamagnetic iron oxide nanoparticles: A next generation contrast agent for magnetic resonance imaging

C Chen, J Ge, Y Gao, L Chen, J Cui… - Wiley Interdisciplinary …, 2022 - Wiley Online Library
As a research hotspot, the development of magnetic resonance imaging (MRI) contrast
agents has attracted great attention over the past decades for improving the accuracy of …

Recent advances in nanomaterials for therapy and diagnosis for atherosclerosis

J Chen, X Zhang, R Millican, J Sherwood… - Advanced drug delivery …, 2021 - Elsevier
Atherosclerosis is a chronic inflammatory disease driven by lipid accumulation in arteries,
leading to narrowing and thrombosis. It affects the heart, brain, and peripheral vessels and is …

[HTML][HTML] Molecularly targeted nanomedicine enabled by inorganic nanoparticles for atherosclerosis diagnosis and treatment

X Zhang, F Centurion, A Misra, S Patel, Z Gu - Advanced drug delivery …, 2023 - Elsevier
Atherosclerosis, a chronic cardiovascular disease caused by plaque development in
arteries, remains a leading cause of morbidity and mortality. Atherosclerotic plaques are …

Nanotechnology for cardiovascular diseases

Q Hu, Z Fang, J Ge, H Li - The Innovation, 2022 - cell.com
Cardiovascular diseases have become the major killers in today's world, among which
coronary artery diseases (CADs) make the greatest contributions to morbidity and mortality …

[HTML][HTML] Advances in drug delivery to atherosclerosis: Investigating the efficiency of different nanomaterials employed for different type of drugs

B Perera, Y Wu, NT Nguyen, HT Ta - Materials Today Bio, 2023 - Elsevier
Atherosclerosis is the build-up of fatty deposits in the arteries. Atherosclerosis is the main
underlying cause of cardiovascular diseases and the leading cause of global morbidity and …

Multimodal molecular imaging: current status and future directions

M Wu, J Shu - Contrast media & molecular imaging, 2018 - Wiley Online Library
Molecular imaging has emerged at the end of the last century as an interdisciplinary method
involving in vivo imaging and molecular biology aiming at identifying living biological …

A Spiky Silver‐Iron Oxide Nanoparticle for Highly Efficient Targeted Photothermal Therapy and Multimodal Imaging of Thrombosis

KX Vazquez‐Prada, SS Moonshi, Y Wu, F Akther… - Small, 2023 - Wiley Online Library
Thrombosis and its complications are responsible for 30% of annual deaths. Limitations of
methods for diagnosing and treating thrombosis highlight the need for improvements …

Targeted molecular imaging of cardiovascular diseases by iron oxide nanoparticles

KX Vazquez-Prada, J Lam, D Kamato… - … and Vascular Biology, 2021 - Am Heart Assoc
Cardiovascular disease is one of the major contributors to global disease burden.
Atherosclerosis is an inflammatory process that involves the accumulation of lipids and …

Immunological effects of iron oxide nanoparticles and iron-based complex drug formulations: Therapeutic benefits, toxicity, mechanistic insights, and translational …

A Shah, MA Dobrovolskaia - Nanomedicine: Nanotechnology, Biology and …, 2018 - Elsevier
Nanotechnology offers several advantages for drug delivery. However, there is the need for
addressing potential safety concerns regarding the adverse health effects of these unique …